News
BIOFABRI and BHARAT BIOTECH partner to develop, manufacture and distribute a novel TB vaccine, MTBVAC.
• This partnership will guarantee the supply of TB vaccines in more than 70 countries…
Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials
Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis…
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG Vaccine
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG Vaccine…
MTBVAC in new-borns Phase 2a trial completed its enrolment
MTBVAC in new-borns Phase 2a trial completed its enrolment…
The Minister of Health Carolina Darias visits the facilities of the Zendal Group
The Minister of Health Carolina Darias visits the facilities of the Zendal Groupvacuna…
Zendal is committed to the creation of a biotechnological pole Galicia-North of Portugal
Zendal is committed to the creation of a biotechnological pole Galicia-North of Portugal…
A study of tuberculosis in macaque models shows that the new vaccine MTBVAC offers better protection than the current BCG vaccine
A study of tuberculosis in macaque models shows that the new vaccine MTBVAC created by…
A USC SARS-COV-2 vaccine project and animal paratuberculosis mycobacteria research, winners of the II International Zendal Awards
A USC SARS-COV-2 vaccine project and animal paratuberculosis mycobacteria research,…
Biofabri of Zendal Group has been selected by the CEPI as a strategic facility to increase the manufacturing capacity of Covid-19 vaccines at an international scale
Biofabri of Zendal Group has been selected by the CEPI as a strategic facility to…
Zendal Groups biopharmaceutical facilities received today a visit by the Science and Innovation Minister, Pedro Duque
Zendal Groups biopharmaceutical facilities received today a visit by the Science and…
